The performance of companies tied to flagship drugs like Viagra presents a complex investment landscape . While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the loss of exclusivity in key markets has introduced considerable volatility. Investors are now facing the effect of rival medicat